{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:18:44Z","timestamp":1788459524345,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100016003","name":"Istanbul University Cerrahpa\u015fa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100016003","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate bone mineral density (BMD) in postmenopausal women with prolactinoma diagnosed during the premenopausal period and to compare skeletal outcomes according to prolactin status during drug-free follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cross-sectional single-center study included 42 postmenopausal women with prolactinoma. Patients were classified as hyperprolactinemic or normoprolactinemic based on serum prolactin levels at the last follow-up visit. BMD was assessed by dual-energy X-ray absorptiometry at the lumbar spine and femoral neck. Clinical variables were compared between groups. Correlation analysis, receiver operating characteristic (ROC) analysis, and multivariable logistic regression were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Lumbar spine BMD was significantly lower in hyperprolactinemic patients than in normoprolactinemic patients (0.861\u2009\u00b1\u20090.124 vs. 0.960\u2009\u00b1\u20090.129\u00a0g\/cm\u00b2,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.022), whereas femoral neck BMD did not differ. Patients with hyperprolactinemia had longer cumulative exposure to hyperprolactinemia and required longer and higher-dose cabergoline treatment. Baseline prolactin levels were higher in patients with osteoporosis and showed potential discriminatory value for identifying osteoporosis (AUC\u2009=\u20090.861). Lumbar spine BMD and T-scores were inversely correlated with prolactin levels. In multivariable analysis, baseline prolactin level remained independently associated with low BMD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Persistent hyperprolactinemia is associated with lower lumbar spine BMD in postmenopausal women with prolactinoma. Baseline prolactin level and cumulative exposure to prolactin excess appear to be important contributors to skeletal deterioration, supporting the need for routine bone health assessment during long-term follow-up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11102-026-01724-3","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:57:11Z","timestamp":1783072631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Does persistent hyperprolactinemia contribute to bone loss independently of estrogen deficiency in postmenopausal women?"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1641-5898","authenticated-orcid":false,"given":"Ali","family":"Tunc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1906-0535","authenticated-orcid":false,"given":"Ilkin","family":"Muradov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5174-4606","authenticated-orcid":false,"given":"Mehmet Umut","family":"Capar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9281-1771","authenticated-orcid":false,"given":"Banu Betul","family":"Kocaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9677-8938","authenticated-orcid":false,"given":"Mayis","family":"Farajli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebnem","family":"Yogurtcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oguz Alp","family":"Baykal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabriye Sibel","family":"Taze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6803-4977","authenticated-orcid":false,"given":"Emre","family":"Durcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6233-5418","authenticated-orcid":false,"given":"Serdar","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6207-7941","authenticated-orcid":false,"given":"Hande Mefkure","family":"Ozkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8329-140X","authenticated-orcid":false,"given":"Pinar","family":"Kadioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"1724_CR1","doi-asserted-by":"crossref","unstructured":"Clinical practice. Prolactinoma. N Engl J Med, 349 (2003) pp. 2035\u20132041","DOI":"10.1056\/NEJMcp025334"},{"issue":"6","key":"1724_CR2","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1080\/07853890410033892","volume":"36","author":"J Harris","year":"2004","unstructured":"Harris J et al (2004) Prolactin and the prolactin receptor: new targets of an old hormone. Ann Med 36(6):414\u2013425","journal-title":"Ann Med"},{"key":"1724_CR3","doi-asserted-by":"crossref","unstructured":"di Filippo L et al (2020) Hyperprolactinemia bone Pituitary23 3 : 314\u2013321","DOI":"10.1007\/s11102-020-01041-3"},{"issue":"4","key":"1724_CR4","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/jcb.22161","volume":"107","author":"D Seriwatanachai","year":"2009","unstructured":"Seriwatanachai D, Krishnamra N, van Leeuwen JP (2009) Evidence for direct effects of prolactin on human osteoblasts: Inhibition of cell growth and mineralization. J Cell Biochem 107(4):677\u2013685","journal-title":"J Cell Biochem"},{"issue":"3","key":"1724_CR5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.bone.2007.11.008","volume":"42","author":"D Seriwatanachai","year":"2008","unstructured":"Seriwatanachai D, Thongchote K, Charoenphandhu N et al (2008) Prolactin directly enhances bone turnover by raising osteoblastexpressed receptor activator of nuclear factor kappaB ligand\/osteoprotegerin ratio. Bone 42(3):535\u2013546","journal-title":"Bone"},{"key":"1724_CR6","doi-asserted-by":"crossref","unstructured":"Naliato EC, de Oliveira et al (2008) Bone density in women with prolactinoma treated with dopamine agonists. Pituitary 11.1 : 21\u201328","DOI":"10.1007\/s11102-007-0064-4"},{"issue":"4","key":"1724_CR7","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1210\/er.2018-00005","volume":"39","author":"G Mazziotti","year":"2018","unstructured":"Mazziotti G, Frara S, Giustina A (2018) Pituitary diseases and bone. Endocr Rev 39(4):440\u2013488","journal-title":"Endocr Rev"},{"issue":"3","key":"1724_CR8","first-page":"692","volume":"75","author":"BM Biller","year":"1992","unstructured":"Biller BM et al (1992) Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea. J Clin Endocrinol Metabolism 75(3):692\u2013697","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"3","key":"1724_CR9","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1210\/jcem.83.3.4674","volume":"83","author":"Di Somma","year":"1998","unstructured":"Di Somma, Carolina et al (1998) Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males. J Clin Endocrinol Metabolism 83(3):807\u2013813","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"2","key":"1724_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S et al (2011) Diagnosis and treatment of hyperprolactinemia: An endocrine society clinical practice guideline. J Clin Endocrinol Metabolism 96(2):273\u2013288","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"12","key":"1724_CR11","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","volume":"19","author":"S Petersenn","year":"2023","unstructured":"Petersenn S et al (2023) Diagnosis and management of prolactin-secreting pituitary adenomas: A pituitary society international consensus statement. Nat Reviews Endocrinol 19(12):722\u2013740","journal-title":"Nat Reviews Endocrinol"},{"issue":"2","key":"1724_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/17446651.2018.1434412","volume":"13","author":"RS Auriemma","year":"2018","unstructured":"Auriemma RS, De Alcubierre D, Pirchio R, Pivonello R, Colao A (2018) The effects of hyperprolactinemia and its control on metabolic diseases. Expert Rev Endocrinol Metab 13(2):99\u2013106. https:\/\/doi.org\/10.1080\/17446651.2018.1434412","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"3","key":"1724_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.tem.2006.02.005","volume":"17","author":"N Ben-Jonathan","year":"2006","unstructured":"Ben-Jonathan N, Hugo ER, Brandebourg TD, LaPensee CR (2006) Focus on prolactin as a metabolic hormone. Trends Endocrinol Metab 17(3):110\u2013116. https:\/\/doi.org\/10.1016\/j.tem.2006.02.005","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"1724_CR14","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1046\/j.1365-2265.1998.00403.x","volume":"48","author":"Y Greenman","year":"1998","unstructured":"Greenman Y, Tordjman K, Stern N (1998) Increased body weight associated with prolactin secreting pituitary adenomas: Weight loss with normalization of prolactin levels. Clin Endocrinol 48(5):547\u2013553","journal-title":"Clin Endocrinol"},{"issue":"4","key":"1724_CR15","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/BF03345182","volume":"26","author":"A Tuzcu","year":"2003","unstructured":"Tuzcu A, Bahceci M, Dursun M, Turgut C, Bahceci S (2003) Insulin sensitivity and hyperprolactinemia. J Endocrinol Invest 26(4):341\u2013346","journal-title":"J Endocrinol Invest"},{"key":"1724_CR16","doi-asserted-by":"crossref","unstructured":"Mazziotti G et al (2011) High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas. Pituitary 14.4 : 299\u2013306","DOI":"10.1007\/s11102-011-0293-4"},{"key":"1724_CR17","doi-asserted-by":"crossref","unstructured":"Shibli-Rahhal A, Schlechte J (2009) The effects of hyperprolactinemia on bone and fat. Pituitary 12.2 : 96\u2013104","DOI":"10.1007\/s11102-008-0097-3"},{"issue":"5","key":"1724_CR18","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1210\/jcem-64-5-1021","volume":"64","author":"JANET SCHLECHTE","year":"1987","unstructured":"SCHLECHTE JANET et al (1987) Forearm and vertebral bone mineral in treated and untreated hyperprolactinemic amenorrhea. J Clin Endocrinol Metabolism 64(5):1021\u20131026","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"1","key":"1724_CR19","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1038\/s41598-021-84606-x","volume":"11","author":"L Andereggen","year":"2021","unstructured":"Andereggen L et al (2021) Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas. Sci Rep 11(1):5122","journal-title":"Sci Rep"},{"key":"1724_CR20","doi-asserted-by":"crossref","unstructured":"Uygur M, Melin et al (2024) Modern approach to bone comorbidity in prolactinoma. Pituitary 27.6 : 802\u2013812","DOI":"10.1007\/s11102-024-01469-x"},{"issue":"4","key":"1724_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.tem.2023.01.006","volume":"34","author":"M Uygur","year":"2023","unstructured":"Uygur M, Melin et al (2023) New tools for bone health assessment in secreting pituitary adenomas. Trends Endocrinol Metabolism 34(4):231\u2013242","journal-title":"Trends Endocrinol Metabolism"},{"key":"1724_CR22","doi-asserted-by":"crossref","unstructured":"Casanueva FF et al (2017) Criteria for the definition of pituitary tumor centers of excellence (PTCOE): a pituitary society statement. Pituitary 20.5 : 489\u2013498","DOI":"10.1007\/s11102-017-0838-2"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01724-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01724-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01724-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:42:06Z","timestamp":1788457326000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-026-01724-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1724"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01724-3","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"15 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Ethics Committee of Istanbul University-Cerrahpa\u015fa, Cerrahpa\u015fa Faculty of Medicine (E-83460662-050.04-1513310). The study was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all patients.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"116"}}